TITLE

Atrial natriuretic peptide in dehydrated Long-Evans rats and Brattleboro rats

AUTHOR(S)
Ogawa, Kazuya; Henry, Mark A.; Tange, John; Woodcock, Elizabeth A.; Johnston, Colin I.
PUB. DATE
March 1987
SOURCE
Kidney International;Mar1987, Vol. 31 Issue 3, p760
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Atrial natriuretic peptide (ANP) was measured by radioimmunoassay in atrial and plasma extracts from normal Long-Evans (LE) rats and Brattleboro-strain diabetes insipidus (DI) rats. LE rats, dehydrated for 72 hours, had an increased plasma osmolality and plasma vasopressin. They also demonstrated a higher atrial immunoreactive ANP (IR-ANP) content than hydrated animals (72 hr dehydration: 178.2 ± 30.4 μg/g wet weight atria, mean ± SE, control: 60.4 ± 8.2; P < 0.001). Plasma IR-ANP in dehydrated LE rats tended to be lower than hydrated LE but this was not statistically significant [72 hr dehydration: 61.9 ± 5.9 pg/ml, control: 82.4 ± 8.2]. IR-ANP concentration in atrial extracts from DI rats, without detectable plasma vasopressin levels but with increased plasma osmolality, was not different from that in hydrated LE rats (DI: 100.6 ± 13.2 μg/g). There was also no significant difference between plasma IR-ANP in DI and hydrated LE rats (DI: 100.2 ± 11.9 pg/mi). The atrial IR-ANP concentration in DI rats was decreased by infusion with either arginine-vasopressin (AVP) or l-deamino-8-arginine vasopressin (DDAVP), and plasma IR-ANP was increased significantly by both infusions (AVP' 171.3 ± 18.1 pg/ml, DDAVP: 179.5 ± 24.6). Thus, changes in atrial and plasma IR-ANP concentration appeared to be associated with changes m water balance but not with plasma AVP levels, indicating that the changes, in volume may be a .more important factor controlling ANP release m vivo than vasopressin itself.
ACCESSION #
17671357

 

Related Articles

  • Effects of atrial natriuretic peptide in clinical acute renal failure. Rahman, S. Noor; Kim, Grace E.; Mathew, Alan S.; Goldberg, Carol A.; Allgren, Robin; Schrier, Robert W.; Conger, John D. // Kidney International;Jun1994, Vol. 45 Issue 6, p1731 

    Fifty-three consenting patients meeting clinical and urine composition criteria for established intrinsic ARF were assigned to two treatment groups. Group I patients were treated with human atrial natriuretic peptide (ANP) with or without diuretics. Groups II patients were treated with or...

  • The heart as an endocrine organ. Sagnella, Guiseppe A. // Biologist;Dec2002, Vol. 49 Issue 6, p275 

    Discusses the role of the heart in the control of body sodium, an important determinant of the extracellular fluid volume and thereby of total blood volume. Details on the discovery of atrial natriuretic peptide in the heart; Importance of atrial natriuretic peptide as a natriuretic factor;...

  • Corin: an ANP protease that may regulate sodium reabsorption in nephrotic syndrome. Klein, Janet D. // Kidney International;Oct2010, Vol. 78 Issue 7, p635 

    The serine/threonine protease corin, which proteolytically activates atrial natriuretic peptide (ANP), is reduced in the kidneys of animals with nephrotic syndrome and glomerular nephritis. Polzin et al. provide evidence for a linkage between the decreased corin and β-epithelial sodium...

  • Atrial natriuretic peptide in diabetic nephropathy. Robert Zietse; Weimar, Willem; Schalekamp, Maarten A. // Kidney International Supplement;Sep1997, Issue 60, pS-33 

    Investigates the atrial natriuretic peptide (ANP) in diabetic nephropathy. Derangement of glomerular barrier function; Imitation of the early effects of diabetes on the kidney through infusion with an ANP; Use of ANP diagnostically to identify the patients who will develop diabetic nephropathy.

  • Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair. Harm Feringa; Don Poldermans; Patrick Klein; Jerry Braun; Robert Klautz; Ron van Domburg; Arnoud van der Laarse; Ernst van der Wall; Robert Dion; Jeroen Bax // International Journal of Cardiovascular Imaging;Apr2007, Vol. 23 Issue 2, p159 

    AbstractBackground and aim??N-terminal pro-B-type natriuretic peptide (NT-proBNP) has diagnostic and prognostic value in patients with heart failure. The present prospective study was designed to assess whether changes in NT-proBNP levels after surgical mitral valve repair reflect changes in...

  • Metabolic Targets of Cardiac Hormones' Therapeutic Anti-Cancer Effects. Vesely, David L. // Current Pharmaceutical Design;3/21/2010, Vol. 16 Issue 9, p1159 

    The heart is a sophisticated endocrine gland synthesizing a family of peptide hormones by three different genes. These cardiac hormones are stored as 3 prohormones, i.e. atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) prohormones. Within the...

  • Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease. Houweling, Arjan C.; van Borren, Marcel M.; Moorman, Antoon F.M.; Christoffels, Vincent M. // Cardiovascular Research;Sep2005, Vol. 67 Issue 4, p583 

    Abstract: The endocrine function of the heart was shown by the identification of a potent inhibitor of renal tubular NaCl reabsorbtion, atrial natriuretic peptide/factor (ANP), in atrial extracts. Since then, Nppa, the gene encoding ANP, has become an important tool for molecular and...

  • Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure. Mariano-Goulart, Denis; Eberlé, Marie-Claude; Boudousq, Vincent; Hejazi-Moughari, Azadeh; Piot, Christophe; Caderas de Kerleau, Charles; Verdier, Régis; Barge, Marie-Luce; Comte, Frédéric; Bressot, Nicole; Rossi, Michel; Kotzki, Pierre-Olivier // European Journal of Heart Failure;Aug2003, Vol. 5 Issue 4, p481 

    This study sought to investigate whether the presence of right ventricular systolic dysfunction with pre-existing left ventricular systolic dysfunction is associated with higher plasma brain natriuretic peptide (BNP) levels, compared with patients with isolated left ventricular dysfunction....

  • Mechanisms of atrial natriuretic peptide secretion from the atrium. Dietz, John R. // Cardiovascular Research;Oct2005, Vol. 68 Issue 1, p8 

    Abstract: Since the discovery of atrial natriuretic peptide (ANP) more than 20 years ago, numerous studies have focused on the mechanisms regulating ANP secretion. From a physiological standpoint, the most important factor governing ANP secretion is mechanical stretching of the atria, which...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics